Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| CAVA Group, Inc.(CAVA) | 17,507,990 | 9,507,990 | -8,000,000 | $2.17B | $1.07B | 91.41% | -$1.10B |
| Lexicon Pharmaceuticals, Inc.(LXRX) | 136,180,481 | 136,180,481 | 0 | $213.80M | $100.77M | 8.59% | -$113.03M |